Diligence memo · auto-generated · as of July 3, 2026

Irving Specialists Surgical Center LLC

Irving Specialists Surgical Center LLC looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Irving Specialists Surgical Center LLC operates in Medical Devices, based in IRVING.

Sub-sector tags: medical-devices.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Irving Specialists Surgical Center LLC has raised $800K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $800K on 2020-08-15.

Most recent recorded round closed around 2020-08-15.

Valuation (modeled)modeled

Provath models Irving Specialists Surgical Center LLC at approximately $28M (range $480K–$302M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 3.75× the median modeled value of Pre-Seed Medical Devices companies in 2019–2021 (26 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Last raise 5.9 yr ago; this sector typically re-raises about every 16 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 38% of Medical Devices peers (233 compared).

Modeled value ranks above 67% of those peers.

Closest niche peers: Augustine Surgical, Inc., White Mountain Surgical Partners, LLC, Grand Parkway Surgical Institute LLC, Halo Diagnostics Llc, West Texas Surgical Services, LLC.

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.